Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Statins and new-onset diabetes.

Barylski M, Nikolic D, Banach M, Toth PP, Montalto G, Rizzo M.

Curr Pharm Des. 2014;20(22):3657-64. Review.

PMID:
24040871
2.

Statins and their increased risk of inducing diabetes.

Agouridis AP, Kostapanos MS, Elisaf MS.

Expert Opin Drug Saf. 2015;14(12):1835-44. doi: 10.1517/14740338.2015.1096343. Review.

PMID:
26437128
3.

Statin therapy and related risk of new-onset type 2 diabetes mellitus.

Ruscica M, Macchi C, Morlotti B, Sirtori CR, Magni P.

Eur J Intern Med. 2014 Jun;25(5):401-6. doi: 10.1016/j.ejim.2014.03.003. Review.

PMID:
24685426
4.

Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?

Navarese EP, Szczesniak A, Kolodziejczak M, Gorny B, Kubica J, Suryapranata H.

Am J Cardiovasc Drugs. 2014 Apr;14(2):79-87. doi: 10.1007/s40256-013-0053-0.

5.

Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.

Izzo R, de Simone G, Trimarco V, Giudice R, De Marco M, Di Renzo G, De Luca N, Trimarco B.

Nutr Metab Cardiovasc Dis. 2013 Nov;23(11):1101-6. doi: 10.1016/j.numecd.2012.11.002.

PMID:
23419735
6.

Statin treatment, new-onset diabetes, and other adverse effects: a systematic review.

Bang CN, Okin PM.

Curr Cardiol Rep. 2014 Mar;16(3):461. doi: 10.1007/s11886-013-0461-4. Review.

PMID:
24464306
7.

Statin-associated incident diabetes: a literature review.

Park ZH, Juska A, Dyakov D, Patel RV.

Consult Pharm. 2014;29(5):317-34. doi: 10.4140/TCP.n.2014.317. Review.

PMID:
24849689
8.

Statin therapy and new-onset diabetes: molecular mechanisms and clinical relevance.

Banach M, Malodobra-Mazur M, Gluba A, Katsiki N, Rysz J, Dobrzyn A.

Curr Pharm Des. 2013;19(27):4904-12. Review.

PMID:
23278491
9.

The good and bad effects of statins on insulin sensitivity and secretion.

Muscogiuri G, Sarno G, Gastaldelli A, Savastano S, Ascione A, Colao A, Orio F.

Endocr Res. 2014;39(4):137-43. doi: 10.3109/07435800.2014.952018. Review.

PMID:
25208056
10.

[STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].

Lavie G, Cohen S.

Harefuah. 2015 Jun;154(6):382-6, 404. Review. Hebrew.

PMID:
26281083
11.

An assessment by the Statin Diabetes Safety Task Force: 2014 update.

Maki KC, Ridker PM, Brown WV, Grundy SM, Sattar N, The Diabetes Subpanel of the National Lipid Association Expert Panel.

J Clin Lipidol. 2014 May-Jun;8(3 Suppl):S17-29. doi: 10.1016/j.jacl.2014.02.012.

PMID:
24793439
12.

Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.

Minder CM, Blumenthal RS, Blaha MJ.

Curr Opin Cardiol. 2013 Sep;28(5):554-60. doi: 10.1097/HCO.0b013e32836429e6. Review.

PMID:
23928920
13.

Is statin-induced diabetes clinically relevant? A comprehensive review of the literature.

Bell DS, DiNicolantonio JJ, O'Keefe JH.

Diabetes Obes Metab. 2014 Aug;16(8):689-94. doi: 10.1111/dom.12254. Review.

PMID:
24373206
14.

The role of statins in the treatment of type 2 diabetes mellitus: an update.

Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP.

Curr Pharm Des. 2014;20(22):3665-74. Review. Erratum in: Curr Pharm Des. 2015;21(24):3565.

PMID:
24040875
15.

Statins and diabetes: the good, the bad, and the unknown.

Axsom K, Berger JS, Schwartzbard AZ.

Curr Atheroscler Rep. 2013 Feb;15(2):299. doi: 10.1007/s11883-012-0299-z. Review.

PMID:
23299640
16.

Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.

Bruckert E, Ferrières J.

Arch Cardiovasc Dis. 2014 Mar;107(3):188-200. doi: 10.1016/j.acvd.2014.01.011.

17.

[Statin treatment causes an increased risk of type 2 diabetes].

Solis AB, Pilemann-Lyberg S, Gæde P.

Ugeskr Laeger. 2014 Feb 3;176(3):227-31. Review. Danish.

PMID:
24629749
18.

Statin-Associated Diabetes Mellitus: Review and Clinical Guide.

Backes JM, Kostoff MD, Gibson CA, Ruisinger JF.

South Med J. 2016 Mar;109(3):167-73. doi: 10.14423/SMJ.0000000000000423. Review.

PMID:
26954655
19.

Statins and diabetes risk: how real is it and what are the mechanisms?

Robinson JG.

Curr Opin Lipidol. 2015 Jun;26(3):228-35. doi: 10.1097/MOL.0000000000000172. Review.

PMID:
25887679
20.

Statins and risk of new-onset diabetes mellitus.

Shah RV, Goldfine AB.

Circulation. 2012 Oct 30;126(18):e282-4. doi: 10.1161/CIRCULATIONAHA.112.122135. No abstract available.

Items per page

Supplemental Content

Support Center